SELLAS Life Sciences Group (SLS) Q2 2025 Earnings

May 13Confirmed
Q3 2024
Q4 2024
Q1 2025
Q2 2025
-0.17
-0.14
-0.1
-0.06

Details

Expected EPS
-0.105
Actual EPS
-0.07
Surprise EPS
0.03
Surprise Percent
+33.33%

Description

⁨SELLAS Life Sciences Group⁩ (⁦SLS⁩) has reported earnings of ⁦-0.07⁩ per share for ⁦Q2 2025⁩.

0 Comments

Share your thoughts